首页>
外国专利>
The anticancer agent emulsion and its manufacturing method null which for target chemotherapy possess stability and the controlled release operation which are improved
The anticancer agent emulsion and its manufacturing method null which for target chemotherapy possess stability and the controlled release operation which are improved
展开▼
机译:具有针对目标化疗的稳定性和控释操作得到改善的抗癌剂乳液及其制备方法无效
展开▼
页面导航
摘要
著录项
相似文献
摘要
PURPOSE: To obtain the subject emulsion capable of effectively distributing an anticancer agent to a tumor part and simultaneously improving the target accuracy of the anticancer agent, comprising a water phase containing the anticancer agent and an oil phase containing an oil and a HCO-60 hydrophilic surfactant. CONSTITUTION: An oil phase containing an oil (preferably lipiodol) in an amount of 10-30wt.% based on a prepared emulsion and a hydrophilic surfactant HCO-60 (polyoxyethylene hydrogenated castor oil having 14 HLB) in an amount of 0.1-2.0wt.%, preferably 0.5-1.5wt.% based on the prepared emulsion is formulated with an aqueous solution of an anticancer agent, then stirred in a homogenizer at 50-100 deg.C to give a mixture, which is emulsified to give the objective emulsion. Adriamycin hydrochloride, bleomycin hydrochloride, mitomycin hydrochloride, cytosine C, cyclophosphamide, cytosine arabinoside, methotrexate, actinomycin, cisplastin, daunomycin hydrochloride, and epirubicin hydrochloride are cited as the anticancer agent.
展开▼